Efficacy and safety of aztreonam-clindamycin versus tobramycin-clindamycin in the treatment of lower respiratory tract infections caused by aerobic gram-negative bacilli.

Benzer Materyaller

• Multidrug resistant Gram-negative bacilli in lower respiratory tract infections
  Yazar:: Vishwanath, Shashidhar, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Is There Complete Cross-Resistance of Gram-Negative Bacilli to Gentamicin and Tobramycin?
  Yazar:: Crowe, C. C., ve diğerleri
  Baskı/Yayın Bilgisi: (1972)
• Bacteriological Profile and Antibiotic Susceptibility Patterns of Gram-negative Bacilli Isolated from Lower Respiratory Tract Infections
  Yazar:: Divya Atray, ve diğerleri
  Baskı/Yayın Bilgisi: (2023-01-01)
• In Vitro Activity of Plazomicin Compared to Amikacin, Gentamicin, and Tobramycin against Multidrug-Resistant Aerobic Gram-Negative Bacilli
  Yazar:: Fleischmann, Wim A., ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Activities of aztreonam and new cephalosporins against infrequently isolated gram-negative bacilli.
  Yazar:: Strandberg, D A, ve diğerleri
  Baskı/Yayın Bilgisi: (1983)